These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32446832)

  • 1. A phase 2b, randomized clinical trial of tapinarof cream for the treatment of plaque psoriasis: Secondary efficacy and patient-reported outcomes.
    Stein Gold L; Bhatia N; Tallman AM; Rubenstein DS
    J Am Acad Dermatol; 2021 Mar; 84(3):624-631. PubMed ID: 32446832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis.
    Paller AS; Stein Gold L; Soung J; Tallman AM; Rubenstein DS; Gooderham M
    J Am Acad Dermatol; 2021 Mar; 84(3):632-638. PubMed ID: 32502588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
    Lebwohl MG; Stein Gold L; Strober B; Papp KA; Armstrong AW; Bagel J; Kircik L; Ehst B; Hong HC; Soung J; Fromowitz J; Guenthner S; Piscitelli SC; Rubenstein DS; Brown PM; Tallman AM; Bissonnette R
    N Engl J Med; 2021 Dec; 385(24):2219-2229. PubMed ID: 34879448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis.
    Robbins K; Bissonnette R; Maeda-Chubachi T; Ye L; Peppers J; Gallagher K; Kraus JE
    J Am Acad Dermatol; 2019 Mar; 80(3):714-721. PubMed ID: 30612986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tapinarof cream for the treatment of plaque psoriasis: Efficacy and safety results from 2 Japanese phase 3 trials.
    Igarashi A; Tsuji G; Fukasawa S; Murata R; Yamane S
    J Dermatol; 2024 Oct; 51(10):1269-1278. PubMed ID: 39150292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials.
    Silverberg JI; Eichenfield LF; Hebert AA; Simpson EL; Stein Gold L; Bissonnette R; Papp KA; Browning J; Kwong P; Korman NJ; Brown PM; Rubenstein DS; Piscitelli SC; Somerville MC; Tallman AM; Kircik L
    J Am Acad Dermatol; 2024 Sep; 91(3):457-465. PubMed ID: 38777187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis.
    Peppers J; Paller AS; Maeda-Chubachi T; Wu S; Robbins K; Gallagher K; Kraus JE
    J Am Acad Dermatol; 2019 Jan; 80(1):89-98.e3. PubMed ID: 30554600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial.
    Strober B; Stein Gold L; Bissonnette R; Armstrong AW; Kircik L; Tyring SK; Piscitelli SC; Brown PM; Rubenstein DS; Tallman AM; Lebwohl MG
    J Am Acad Dermatol; 2022 Oct; 87(4):800-806. PubMed ID: 35772599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VTAMA
    Gupta AK; Ravi SP; Vincent K; Abramovits W
    Skinmed; 2022; 20(4):298-300. PubMed ID: 35976021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics.
    Jett JE; McLaughlin M; Lee MS; Parish LC; DuBois J; Raoof TJ; Tabolt G; Wilson T; Somerville MC; DellaMaestra W; Piscitelli SC
    Am J Clin Dermatol; 2022 Jan; 23(1):83-91. PubMed ID: 34713415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tapinarof for the treatment of psoriasis.
    Nogueira S; Rodrigues MA; Vender R; Torres T
    Dermatol Ther; 2022 Dec; 35(12):e15931. PubMed ID: 36226669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials.
    Desai SR; Stein Gold L; Cameron MC; Golant A; Lewitt GM; Bruno MJ; Martin G; Brown PM; Rubenstein DS; Butners V; Tallman AM
    Dermatol Ther (Heidelb); 2023 Oct; 13(10):2443-2460. PubMed ID: 37697121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tapinarof cream 1% once daily for the treatment of adults with mild to severe plaque psoriasis: A novel topical therapy targeting the aryl hydrocarbon receptor.
    Armstrong AW; McConaha JL
    J Manag Care Spec Pharm; 2023 Dec; 29(12-a Suppl):S2-S14. PubMed ID: 38014659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tapinarof cream 1% once daily for the treatment of adults with mild to severe plaque psoriasis: A novel topical therapy targeting the aryl hydrocarbon receptor.
    Armstrong AW; McConaha JL
    J Manag Care Spec Pharm; 2023 Dec; 29(12-a Suppl):S1-S13. PubMed ID: 38051146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Topical Tapinarof for the Treatment of Plaque Psoriasis.
    Grossmann MC; Pixley JN; Feldman SR
    Ann Pharmacother; 2024 Jan; 58(1):76-85. PubMed ID: 37076998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tapinarof, a Novel, First-in-Class, Topical Therapeutic Aryl Hydrocarbon Receptor Agonist for the Management of Psoriasis.
    Bobonich M; Gorelick J; Aldredge L; Bruno MJ; DiRuggiero D; Martin G; Tallman AM; Gold LS
    J Drugs Dermatol; 2023 Aug; 22(8):779-784. PubMed ID: 37556512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis.
    Kircik L; Zirwas M; Kwatra SG; Lewitt GM; Glover H; Chao T; Brown PM; Rubenstein DS; Tallman AM
    Dermatol Ther (Heidelb); 2024 Jan; 14(1):201-211. PubMed ID: 38123875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study.
    Papp KA; Gooderham M; Droege M; Merritt C; Osborne DW; Berk DR; Thurston AW; Smith VH; Welgus H
    J Drugs Dermatol; 2020 Aug; 19(8):734-740. PubMed ID: 32845114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tapinarof Cream 1%: First Approval.
    Keam SJ
    Drugs; 2022 Jul; 82(11):1221-1228. PubMed ID: 35939180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial.
    Bissonnette R; Bolduc C; Maari C; Nigen S; Webster JM; Tang L; Lyle M
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1516-21. PubMed ID: 22077962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.